Danish Lubna, Siddiq Riffat, Jahan Sarwat, Taneez Mehwish, Khan Manzoor, Sandhu Marva
Sulaiman Bin Abdullah Aba Al-Khail Centre for Interdisciplinary Research in Basic Sciences (CIRBS), International Islamic University Islamabad (IIUI), Islamabad, Pakistan.
Department of Maxillofacial Surgery, Rehman College of Dentistry, Peshawar, Pakistan.
Int J Hepatol. 2020 Jan 23;2020:9185361. doi: 10.1155/2020/9185361. eCollection 2020.
Paracetamol, chemically known as acetaminophen, if taken in higher doses has hepatotoxic potential. Cimetidine by inhibiting the cytochromal enzymes and reducing the production of the toxic metabolite can reduce the hepatotoxic potential while Verapamil can act as a hepatoprotective by maintaining calcium homeostasis. The present study was conducted to study the hepatoprotective activity of Cimetidine and Verapamil against the toxicity induced by paracetamol. In addition to the group receiving only distilled water or 300 mg/kg paracetamol additional groups were added treated with 150 mg/kg Cimetidine and Verapamil alone or both. The Liver function tests and histopathology revealed hepatotoxicity in the group receiving paracetamol (PCM) while normal parameters were observed in the groups receiving Cimetidine and Verapamil. Our results strongly suggested that Cimetidine and Verapamil possess hepatoprotective potential against paracetamol induced hepatotoxicity.
对乙酰氨基酚,化学名称为醋氨酚,若大剂量服用具有肝毒性。西咪替丁通过抑制细胞色素酶并减少有毒代谢物的产生,可降低肝毒性,而维拉帕米可通过维持钙稳态起到肝脏保护作用。本研究旨在探讨西咪替丁和维拉帕米对乙酰氨基酚诱导的毒性的肝脏保护活性。除了仅接受蒸馏水或300毫克/千克对乙酰氨基酚的组外,还添加了单独用150毫克/千克西咪替丁和维拉帕米或两者治疗的额外组。肝功能测试和组织病理学显示,接受对乙酰氨基酚(PCM)的组出现肝毒性,而接受西咪替丁和维拉帕米的组观察到正常参数。我们的结果强烈表明,西咪替丁和维拉帕米对乙酰氨基酚诱导的肝毒性具有肝脏保护潜力。